ABH Healthcare IPO Day 2 Live: Total hits 1.03x; Retail jumps 26% - Check analysts view and more

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights
  • ABH Healthcare IPO reached 1.03x total subscription on Day 2.
  • Retail category surged 26.0% intra-day, moving from 0.73x to 0.92x.
  • QIBs remain heavily subscribed at 8.37x, unchanged from Day 1.
  • The company operates a 150-bed multi-specialty hospital in Ferozepur, Punjab.
  • Financials show revenue growth from ₹41.39 crores in FY24 to ₹52.59 crores in FY26.
powered bylight_fuzz_icon
49269081

*this image is generated using AI for illustrative purposes only.

ABH Healthcare’s IPO achieved full subscription on Day 2, crossing the 1x mark at 1.03x by close of business. The milestone was driven by a sharp 26.0% intra-day jump in Retail subscriptions, which rose from 0.73x to 0.92x in the final hours of trading.

Subscription Status

The issue is now fully subscribed, with the Total figure ticking up from 0.94x to 1.03x in the final hours. While Qualified Institutional Buyers (QIBs) held steady at 8.37x, Retail investors provided the critical momentum needed to close the gap.

Category Day 1 (24-08-2026) Day 2 (25-08-2026) Day 3 (26-08-2026)
QIB 3.45x 8.37x 8.37x
NII (bHNI) 0.07x 0.13x 0.20x
NII (sHNI) 0.01x 0.18x 0.16x
Retail 0.31x 0.62x 0.92x
Total 0.37x 0.88x 1.03x

Intra-day timeline on 26-08-2026

Retail activity intensified after noon, pushing the overall subscription past the full subscription threshold.

Time (IST) QIB NII (bHNI) Retail Total
11:15 8.37x 0.14x 0.73x 0.94x
12:15 8.37x 0.14x 0.79x 0.96x
13:15 8.37x 0.14x 0.82x 0.98x
14:15 8.37x 0.14x 0.85x 1.00x
15:15 8.37x 0.14x 0.89x 1.01x
16:15 8.37x 0.16x 0.92x 1.03x

Momentum highlights:

  • Retail: Jumped +26.0% today (from 0.73x to 0.92x)
  • Total: Jumped +9.6% today (from 0.94x to 1.03x)

About the Company

ABH Healthcare Limited operates a 150-bed multi-specialty tertiary care hospital under the "Anil Baghi Hospital" brand in Ferozepur, Punjab. Founded in 2021 and acquiring the hospital business in 2022, it offers 25 medical specialties including cardiac sciences and neurology. The company is led by U.S.-trained doctors Dr. Kamal Baghi (MD) and Dr. Saurabh Baghi (CEO).

Financial Highlights

The company reported consistent revenue growth over the last three years. Total equity increased from ₹6.35 crores in FY24 to ₹17.34 crores in FY26.

Particulars FY24 FY25 FY26
Revenue (₹ crores) 41.39 49.32 52.59
PAT (₹ crores) 1.66 5.35 5.64
Total Equity (₹ crores) 6.35 11.69 17.34

Revenue grew steadily from ₹41.39 crores in FY24 to ₹52.59 crores in FY26. Profit after tax also improved significantly, rising from ₹1.66 crores to ₹5.64 crores in the same period.

Objects of the Issue

  • Repayment/prepayment of certain borrowings: ₹17.00 crores
  • Funding working capital requirements: ₹5.00 crores
  • Funding inorganic growth through unidentified acquisitions and general corporate purposes

Risk Factors

  • Limited operating history as a company since incorporation in March 2021.
  • Geographic revenue concentration risk with 100% revenue from its single hospital in Ferozepur.
  • High debt-to-equity ratio of 3.20 in Fiscal 2026, posing funding risks.

Key Dates

  • Close Date: 2026-08-27
  • Allotment Date: 2026-08-28
  • Listing Date: 2026-09-01

How might the high debt-to-equity ratio of 3.20 impact ABH Healthcare's ability to execute its planned inorganic growth and acquisitions post-IPO?

What are the potential risks associated with the company's 100% revenue concentration in a single hospital location in Ferozepur, and what is the strategy for geographic diversification?

Given the sharp late-day retail surge, how likely is it that the stock will experience significant volatility or a 'listing pop' on September 1st?

like18
dislike

ABH Healthcare IPO Day 2 Live: QIB jumps 142% to 8.37x - Check analysts view and more

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights
  • ABH Healthcare IPO subscribed 0.88x on Day 2, driven by strong QIB interest.
  • QIB category jumped 142.6% to 8.37x, while retail stood at 0.62x.
  • Company reported ₹52.51 crore revenue and ₹5.64 crore PAT in FY 2026.
  • IPO proceeds will fund debt repayment (₹17.00 crores) and working capital (₹5.00 crores).
powered bylight_fuzz_icon
49182580

*this image is generated using AI for illustrative purposes only.

ABH Healthcare’s IPO achieved full subscription on Day 2, crossing the 1x mark at 1.03x by close of business. The milestone was driven by a sharp 26.0% intra-day jump in Retail subscriptions, which rose from 0.73x to 0.92x in the final hours of trading.

Subscription Status

The issue is now fully subscribed, with the Total figure ticking up from 0.94x to 1.03x in the final hours. While Qualified Institutional Buyers (QIBs) held steady at 8.37x, Retail investors provided the critical momentum needed to close the gap.

Category Day 1 (24-08-2026) Day 2 (25-08-2026) Day 3 (26-08-2026)
QIB 3.45x 8.37x 8.37x
NII (bHNI) 0.07x 0.13x 0.20x
NII (sHNI) 0.01x 0.18x 0.16x
Retail 0.31x 0.62x 0.92x
Total 0.37x 0.88x 1.03x

Intra-day timeline on 26-08-2026

Retail activity intensified after noon, pushing the overall subscription past the full subscription threshold.

Time (IST) QIB NII (bHNI) Retail Total
11:15 8.37x 0.14x 0.73x 0.94x
12:15 8.37x 0.14x 0.79x 0.96x
13:15 8.37x 0.14x 0.82x 0.98x
14:15 8.37x 0.14x 0.85x 1.00x
15:15 8.37x 0.14x 0.89x 1.01x
16:15 8.37x 0.16x 0.92x 1.03x

Momentum highlights:

  • Retail: Jumped +26.0% today (from 0.73x to 0.92x)
  • Total: Jumped +9.6% today (from 0.94x to 1.03x)

About the Company

ABH Healthcare Limited operates a 150-bed multi-specialty tertiary care hospital under the "Anil Baghi Hospital" brand in Ferozepur, Punjab. Founded in 2021 and acquiring the hospital business in 2022, it offers 25 medical specialties including cardiac sciences and neurology. The company is led by U.S.-trained doctors Dr. Kamal Baghi (MD) and Dr. Saurabh Baghi (CEO).

Financial Highlights

The company reported consistent revenue growth over the last three years. Total equity increased from ₹6.35 crores in FY24 to ₹17.34 crores in FY26.

Particulars FY24 FY25 FY26
Revenue (₹ crores) 41.39 49.32 52.59
PAT (₹ crores) 1.66 5.35 5.64
Total Equity (₹ crores) 6.35 11.69 17.34

Revenue grew steadily from ₹41.39 crores in FY24 to ₹52.59 crores in FY26. Profit after tax also improved significantly, rising from ₹1.66 crores to ₹5.64 crores in the same period.

Objects of the Issue

  • Repayment/prepayment of certain borrowings: ₹17.00 crores
  • Funding working capital requirements: ₹5.00 crores
  • Funding inorganic growth through unidentified acquisitions and general corporate purposes

Risk Factors

  • Limited operating history as a company since incorporation in March 2021.
  • Geographic revenue concentration risk with 100% revenue from its single hospital in Ferozepur.
  • High debt-to-equity ratio of 3.20 in Fiscal 2026, posing funding risks.

Key Dates

  • Close Date: 2026-08-27
  • Allotment Date: 2026-08-28
  • Listing Date: 2026-09-01

Will the significant disparity between QIB enthusiasm and retail apathy lead to a listing price correction or high volatility for ABH Healthcare?

How might the company's plan to use IPO proceeds for unidentified inorganic acquisitions impact its integration risks and future debt levels?

Given the 100% revenue concentration from a single facility, what is ABH Healthcare's timeline and strategy for geographic diversification to mitigate this risk?

like19
dislike

More News on ABH Healthcare

ABH Healthcare IPO

IPO Open Now
Price Range ₹ 96 – ₹ 102
Min Investment₹ 2,30,400
Issue Size₹ 34.98 Cr.
Lot Size1,200
Date24 Aug - 27 Aug
View IPO Details arrow